Modafinil: Uses, Dosage, Side Effects, and Safety Guide

Modafinil promotes wakefulness through a mechanism that still isn’t fully understood, and it’s approved for exactly three conditions: narcolepsy, obstructive sleep apnea (OSA), and shift work disorder. Because its chemical structure differs from amphetamines and methylphenidate, it’s sometimes described as a “milder” stimulant — but its Schedule IV status and documented abuse potential complicate that reputation. This page covers what modafinil is actually approved for, how it’s dosed, and the warnings that matter most.

The information below reflects current FDA prescribing information for modafinil. It’s meant for general education, so it doesn’t replace advice from a licensed prescriber or pharmacist.

Product Overview

What Is Modafinil?

Modafinil is a wakefulness-promoting agent, first approved by the FDA in 1998 under the brand name Provigil. Because it works differently from amphetamines and methylphenidate, researchers originally hoped it would carry less abuse risk — a hope that later research only partially confirmed.

Active Ingredient

The active ingredient is modafinil, a racemic compound whose two mirror-image forms (R-modafinil and S-modafinil) behave differently in the body, with R-modafinil clearing about three times more slowly.

Brand Name and Generic Name

The original brand name, Provigil, was manufactured by Cephalon. Since the patent expired, generic modafinil tablets have become widely available from multiple manufacturers.

Drug Classification

Modafinil is classified as a wakefulness-promoting agent, distinct in structure from both amphetamines and methylphenidate. Because of its documented potential for misuse, the DEA classifies it as a Schedule IV controlled substance — a lower schedule than the Schedule II stimulants covered elsewhere in this series, but still controlled.

FDA-Approved Uses

Modafinil is approved to improve wakefulness in adults with excessive sleepiness associated with:

• Narcolepsy
• Obstructive sleep apnea (OSA) — specifically for the excessive sleepiness that comes with OSA, not as a treatment for the underlying airway obstruction itself
• Shift work disorder (SWD)

For OSA, the label is explicit that patients should make a maximal effort with CPAP therapy first, since modafinil doesn’t address the obstruction causing the sleepiness.

Evidence-Supported Off-Label Uses

Modafinil has been studied off-label for ADHD, and clinical trials did show a statistically significant reduction in ADHD symptoms. However, the FDA declined to approve it for this use after finding cases of serious rash, including possible Stevens-Johnson syndrome, among study participants. Some clinicians also use it off-label for depression-related fatigue or cognitive symptoms, but this isn’t part of its approved labeling either, and any such use should happen only under individualized prescriber judgment.

How It Works

The exact mechanism behind modafinil’s wake-promoting effect remains unknown. It binds to the dopamine transporter and increases extracellular dopamine in certain brain regions, but unlike amphetamines, it doesn’t appear to work through direct dopamine receptor activation, and its effects aren’t blocked by dopamine receptor antagonists the way amphetamine’s are. This distinct pharmacology is part of why modafinil is described as chemically unrelated to classic stimulants, even though it produces some similar effects.

Product Information Table

Available Strengths

Both strengths are white to off-white, capsule-shaped tablets, distinguished by their debossing.

Because generic modafinil tablets can vary by manufacturer, patients should confirm with their pharmacist if a refilled tablet looks unfamiliar.

Dosage Guide

Modafinil’s dosing is simpler than many medications in this series, since it follows a flat dose per indication rather than weight-based titration.

Narcolepsy or OSA

The recommended dose is 200 mg taken once daily as a single dose in the morning. Doses up to 400 mg per day have been well tolerated in studies, but there’s no consistent evidence that the higher dose provides additional benefit over 200 mg.

Shift Work Disorder

The recommended dose is 200 mg taken once daily, approximately one hour before the start of the work shift.

Adults Only

Because modafinil isn’t approved for any pediatric indication, all of the dosing guidance above applies specifically to adults.

Older Adults

Since modafinil’s clearance may slow with age, prescribers typically consider a lower starting dose and closer monitoring in geriatric patients. In one study of patients with a mean age of 82, plasma modafinil levels ran roughly twice as high as in younger patients taking the same dose.

Kidney Disease

Interestingly, severe kidney impairment didn’t meaningfully change modafinil’s own pharmacokinetics in study data, even though it substantially increased levels of an inactive metabolite. Because of this, modafinil itself doesn’t require a dose adjustment for kidney impairment the way many other medications do.

Liver Disease

Liver function matters much more than kidney function here. In patients with significant cirrhosis, modafinil’s clearance dropped by about 60%, and steady-state blood levels roughly doubled. Because of this, the label specifically requires cutting the dose in half for patients with severe hepatic impairment.

How to Take It

With or Without Food

Patients can take modafinil with or without food, since food doesn’t change the total amount absorbed. Taking it with food may delay the time to peak levels by about an hour, though.

Timing Matters by Indication

For narcolepsy or OSA, modafinil is taken in the morning. For shift work disorder, timing shifts to about an hour before the work shift begins, since the goal is wakefulness during that specific period rather than the daytime in general.

Missed Dose

Because narcolepsy and OSA dosing follows a single morning dose, a missed dose is typically just skipped rather than taken later in the day, since a delayed dose could interfere with nighttime sleep. Patients should check with their prescriber for guidance specific to their situation.

Overdose

Because modafinil overdose can cause agitation, confusion, hallucinations, an irregular heartbeat, or dangerously elevated blood pressure, anyone who suspects an overdose should call Poison Control at 1-800-222-1222 or seek emergency medical care right away. Fatal overdoses have been reported, though almost always in combination with other drugs rather than modafinil alone.

Storage and Disposal

Patients should store modafinil in a secure, ideally locked, location at room temperature, protected from excess heat and moisture. Because it’s a controlled substance, a DEA-authorized take-back program is the preferred disposal method; alternatively, mixing unused tablets with an undesirable substance such as used coffee grounds before sealing and discarding them in household trash is an accepted method.

Benefits

For patients with narcolepsy, OSA-related sleepiness, or shift work disorder, modafinil offers a once-daily option that supports wakefulness without the multiple daily dosing typical of some other stimulant medications. Because its chemical structure differs from amphetamines, some patients tolerate it with fewer of the classic stimulant side effects like jitteriness, though this varies by individual.

Side Effects

Because modafinil affects the nervous and cardiovascular systems, its side effects span both.

Common Side Effects (5% or More)

• Headache (the single most common side effect, affecting roughly a third of patients)
• Nausea
• Nervousness
• Rhinitis (nasal inflammation)
• Diarrhea
• Back pain
• Anxiety
• Insomnia
• Dizziness
• Dyspepsia (indigestion)

Less Common Side Effects

• Dry mouth
• Anorexia (reduced appetite)
• Chest pain
• Elevated blood pressure
• Palpitations
• Constipation

Serious Side Effects

• Serious rash, including Stevens-Johnson syndrome, toxic epidermal necrolysis, or DRESS syndrome
• Angioedema or anaphylaxis
• Multi-organ hypersensitivity reactions, which can involve the liver, heart, and blood cells alongside skin symptoms
• New or worsening psychiatric symptoms, including mania, hallucinations, delusions, or suicidal ideation
• Cardiovascular events, particularly in patients with mitral valve prolapse or left ventricular hypertrophy

Emergency Symptoms

Because these signs can indicate a medical emergency, patients should seek immediate care for:

• Any new rash, especially with fever, blistering, or peeling skin
• Swelling of the face, eyes, lips, tongue, or throat, or difficulty breathing or swallowing
• Chest pain, an irregular heartbeat, or fainting
• New hallucinations, suicidal thoughts, or severe agitation

Drug Interactions

Because modafinil both induces and inhibits different liver enzymes, it interacts with a fairly wide range of medications.

Prescription Drugs

Modafinil speeds up the breakdown of drugs metabolized by CYP3A4/5 — including cyclosporine, midazolam, and triazolam — which can reduce their effectiveness. In the opposite direction, it slows the breakdown of CYP2C19 substrates like phenytoin, diazepam, propranolol, omeprazole, and clomipramine, which can raise their blood levels. Warfarin requires closer INR monitoring when combined with modafinil, and MAOIs call for general caution.

OTC Medicines

Because omeprazole and similar OTC or prescription acid reducers are affected by modafinil’s enzyme inhibition, patients using them regularly should mention this to their prescriber.

Alcohol

The label doesn’t detail a specific interaction between alcohol and modafinil, but combining any wakefulness-promoting agent with alcohol can mask impairment, so caution is still warranted.

Supplements

No specific supplement interactions are flagged in the current label, but patients should disclose all supplement use to their prescriber regardless.

Herbal Products

As with supplements generally, herbal products — particularly those affecting liver enzyme activity or blood pressure — deserve the same disclosure and caution.

Hormonal Contraceptives

This deserves its own callout: modafinil significantly reduces the effectiveness of steroidal contraceptives, including birth control pills, by speeding up their metabolism. This effect lasts through treatment and for one month after stopping modafinil, so patients need an alternative or backup contraceptive method during that entire window.

Warnings

Modafinil’s most distinctive warning covers serious rash, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Because no factors reliably predict who will develop a serious reaction, and because most cases appear within the first one to five weeks of treatment, the label instructs discontinuing modafinil at the first sign of any rash unless it’s clearly unrelated to the drug.

Beyond the rash risk, modafinil carries warnings for angioedema, anaphylaxis, and multi-organ hypersensitivity reactions (which have included at least one fatality in postmarketing reports). It can also cause persistent sleepiness even during treatment, meaning wakefulness may not fully return to normal — patients should be reassessed regularly and cautioned about driving if sleepiness continues. New or worsening psychiatric symptoms and cardiovascular events round out the label’s major warnings, particularly in patients with a psychiatric history or known heart conditions like mitral valve prolapse.

Contraindications

Patients shouldn’t take modafinil if they:

• Have a known hypersensitivity to modafinil, armodafinil, or the product’s inactive ingredients

The label also advises against use in patients with a history of left ventricular hypertrophy or mitral valve prolapse syndrome that previously occurred with other CNS stimulants.

Pregnancy

No adequate, well-controlled studies exist in pregnant women, and animal studies showed developmental toxicity at clinically relevant exposures. Cases of intrauterine growth restriction and spontaneous abortion have been reported in association with modafinil use, though whether these cases were actually caused by the drug remains unclear. Separately, pregnancy registry data have suggested a higher rate of major congenital anomalies among infants exposed to modafinil, a finding that adds meaningful weight to the existing caution. Because of this combined evidence, modafinil should be used during pregnancy only if the potential benefit clearly justifies the potential risk to the fetus, and reliable contraception matters even more given modafinil’s effect on hormonal birth control.

Breastfeeding

It’s not known whether modafinil or its metabolites pass into human breast milk. Because many medications do transfer into human milk, caution is advised when modafinil is used by a nursing parent.

Monitoring Requirements

Throughout treatment, prescribers typically monitor:

• Any new rash, at every visit and between visits
• Blood pressure and heart rate, especially in patients with known cardiovascular risk
• Ongoing degree of sleepiness, to confirm wakefulness has genuinely improved
• Signs of new or worsening psychiatric symptoms
• Signs of misuse or escalating dose-seeking behavior, particularly in patients with a prior history of stimulant or substance misuse

Storage Instructions

Patients should store modafinil at room temperature, protected from excess heat and moisture, in a secure, ideally locked, location, since it is a federally controlled substance.

Frequently Asked Questions

What is modafinil used for?

Modafinil improves wakefulness in adults with excessive sleepiness caused by narcolepsy, obstructive sleep apnea, or shift work disorder. For OSA specifically, it treats the sleepiness rather than the underlying breathing obstruction, so patients typically need to continue CPAP therapy alongside it.

Is modafinil approved for ADHD?

No. Clinical trials did find a statistically significant reduction in ADHD symptoms, but the FDA declined to approve modafinil for this use after cases of serious rash, including possible Stevens-Johnson syndrome, appeared in the study population. Any ADHD use of modafinil today would be entirely off-label.

What is the typical dose of modafinil?

For narcolepsy or OSA, the standard dose is 200 mg once daily in the morning. For shift work disorder, it’s 200 mg once daily, taken about an hour before the work shift starts. Doses up to 400 mg have been studied but don’t show consistent extra benefit over 200 mg.

Why is modafinil taken in the morning (or before a shift)?

Because modafinil promotes wakefulness for hours after each dose, taking it too late in the day can interfere with nighttime sleep. Morning dosing works for narcolepsy and OSA, while shift workers time their dose to align with the start of their work period instead.

Can modafinil be taken by children?

No. Modafinil isn’t approved for any pediatric indication, and its safety and effectiveness haven’t been established in children. Pediatric clinical trials showed a higher risk of serious rash, including cases of possible Stevens-Johnson syndrome, which contributed to this decision.

What is the serious rash risk with modafinil?

Modafinil carries a genuine risk of serious skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS syndrome. Because no factors reliably predict who will develop a serious reaction, and most cases appear within the first few weeks of treatment, patients should stop taking modafinil and seek medical care at the first sign of any new rash.

Does modafinil affect birth control pills?

Yes, significantly. Modafinil speeds up the breakdown of hormonal contraceptives, reducing their effectiveness during treatment and for a full month afterward. Patients using birth control pills need an alternative or backup contraceptive method for that entire window.

Is modafinil addictive?

It has real abuse potential, more than its reputation suggests. Modafinil is a Schedule IV controlled substance, and a formal study found it produced psychoactive and euphoric effects comparable to methylphenidate, a scheduled stimulant. It doesn’t appear to cause a withdrawal syndrome after typical use, but prescribers still monitor for signs of misuse, especially in patients with a history of stimulant abuse.

What are the most common side effects of modafinil?

Headache is by far the most common, affecting roughly a third of patients in clinical trials. Other frequent side effects include nausea, nervousness, nasal inflammation, diarrhea, back pain, anxiety, insomnia, dizziness, and indigestion.

Can modafinil interact with other medications?

Yes, in both directions. It speeds up the clearance of some drugs, including hormonal contraceptives, cyclosporine, and midazolam, while slowing the clearance of others, including phenytoin, diazepam, and warfarin. Patients should disclose their full medication list before starting modafinil.

Is modafinil safe during pregnancy?

The evidence here is more concerning than for many other medications in this series. No adequate human studies exist, animal studies showed developmental toxicity, and pregnancy registry data have suggested a higher rate of major congenital anomalies among exposed infants. Modafinil should only be used during pregnancy if the potential benefit clearly outweighs this risk.

Does modafinil cure sleep apnea?

No. For OSA specifically, modafinil only addresses the excessive daytime sleepiness that results from the condition — it doesn’t treat the underlying airway obstruction. Patients typically need to continue CPAP therapy or another primary OSA treatment alongside modafinil.

Can older adults take modafinil?

Yes, but often at a lower dose. Because modafinil’s clearance may slow with age, prescribers typically start with a reduced dose and monitor more closely in older adults, since blood levels can run meaningfully higher than in younger patients taking the same dose.

What should I do if too much modafinil was taken?

Suspected overdose warrants prompt medical attention, since symptoms can include agitation, confusion, hallucinations, an irregular heartbeat, or dangerously high blood pressure. Patients should call Poison Control at 1-800-222-1222 or go to the nearest emergency room, particularly if other substances were involved.

Does modafinil replace a full night’s sleep?

No. Modafinil promotes wakefulness, but it doesn’t fully restore normal alertness in people who are significantly sleep-deprived, and patients may not even recognize their own remaining sleepiness. Because of this, prescribers reassess sleepiness regularly and caution patients about driving or operating machinery until they know how they respond.

Conclusion

Modafinil fills a specific niche — improving wakefulness in narcolepsy, OSA, and shift work disorder — through a mechanism that remains only partially understood and that genuinely differs from classic stimulants. That said, its reputation as a uniquely “clean” or low-risk option doesn’t fully hold up against its actual label: a real rash warning serious enough to block ADHD approval, Schedule IV status backed by abuse-potential data comparable to methylphenidate, and a more concerning pregnancy safety picture than many alternatives. Patients considering modafinil benefit from weighing these specifics rather than its general reputation.